sulfur hexafluoride lipid-type a microspheres · Bracco · NDA 203684
Lumason
Earliest generic entry, as listed
15 May 2039
Blocked by patent: US 11723869, US 11723869, US 11723869.
Listed patents · 5 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 11723869 | product, use U-3666 | 15 May 2039 |
| US 11723869 | product, use U-3667 | 15 May 2039 |
| US 11723869 | product, use U-3668 | 15 May 2039 |
| US 10232061 | product | 6 Jul 2038 |
| US 10335502 | product | 6 Jul 2038 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 203684 · 001 · RLD | for suspension, intravenous | 60.7MG/25MG | 15 May 2039 |